Regenerative Medical Technology (RMTG) Total Debt Growth (1y) (2020 - 2026)
Regenerative Medical Technology (RMTG) Total Debt Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 12.42% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -57.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 3.78% |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 217,128.60% |
| Jun 30, 2025 | 6,795.82% |
| Mar 31, 2025 | -89.27% |
| Dec 31, 2024 | 25,541.01% |
| Sep 30, 2024 | -99.96% |
| Jun 30, 2024 | -99.76% |
| Mar 31, 2024 | 112.85% |
| Dec 31, 2023 | -99.95% |
| Sep 30, 2023 | 18.57% |
| Jun 30, 2023 | 212,675.01% |
| Mar 31, 2023 | -36.45% |
| Dec 31, 2022 | 193,115.33% |
| Sep 30, 2022 | 187,587.59% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 176,532.49% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |